1. Home
  2. TROX vs SPTX Comparison

TROX vs SPTX Comparison

Compare TROX & SPTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Tronox Holdings plc (UK)

TROX

Tronox Holdings plc (UK)

HOLD

Current Price

$5.87

Market Cap

1.3B

Sector

Industrials

ML Signal

HOLD

Logo Seaport Therapeutics Inc. Common Stock

SPTX

Seaport Therapeutics Inc. Common Stock

N/A

Current Price

$21.07

Market Cap

1.1B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
TROX
SPTX
Founded
2018
N/A
Country
United States
United States
Employees
N/A
N/A
Industry
Major Chemicals
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.3B
1.1B
IPO Year
2012
2026

Fundamental Metrics

Financial Performance
Metric
TROX
SPTX
Price
$5.87
$21.07
Analyst Decision
Hold
Analyst Count
8
0
Target Price
$6.36
N/A
AVG Volume (30 Days)
2.5M
179.3K
Earning Date
05-06-2026
N/A
Dividend Yield
2.07%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$2,898,000,000.00
N/A
Revenue This Year
$6.94
N/A
Revenue Next Year
$5.91
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.86
$17.59
52 Week High
$10.59
$22.98

Technical Indicators

Market Signals
Indicator
TROX
SPTX
Relative Strength Index (RSI) 32.98 58.85
Support Level $5.39 $17.89
Resistance Level $8.61 $22.15
Average True Range (ATR) 0.37 1.98
MACD 0.02 -0.07
Stochastic Oscillator 21.86 62.44

Price Performance

Historical Comparison
TROX
SPTX

About TROX Tronox Holdings plc (UK)

Tronox Holdings PLC is a vertically integrated manufacturer of TiO2 pigment. It operates titanium-bearing mineral sand mines and beneficiation and smelting operations in Australia & South Africa to produce feedstock materials that can be processed into TiO2 for pigment, high-purity titanium chemicals, including titanium tetrachloride, and ultrafine TiO2 used in certain specialty applications. TiO2 and titanium feedstock, are used to produce paints and coatings, as well as plastics, paper, and printing ink. It has three pigment production facilities in the United States, the Netherlands, and Western Australia and three mining operations in Western Australia and South Africa. Europe, the Middle East, and Africa regions contribute the majority of revenue.

About SPTX Seaport Therapeutics Inc. Common Stock

Seaport Therapeutics Inc is a clinical-stage therapeutics company. The company focuses on invention and development of new medicines for patients with depression, anxiety, and other debilitating neuropsychiatric disorders. The company identified clinically validated mechanisms with established efficacy and safety profiles, historically limited by high first-pass metabolism, low bioavailability, and side effects. The company's pipeline products are based on Glyph, company's lymphatic-targeting prodrug technology is designed to bypass first-pass metabolism and thereby enhance a drug's oral bioavailability and reduce side effects.

Share on Social Networks: